Gapping up
In reaction to earnings/guidance:
- GTLB +8.5%, UNFI +6.9%, PLAY +6.3%, GIII +5.6%, HQY +4.2%
Other news:
- KSS +10.4% (Board of Directors enters into three-week exclusive negotiations with Franchise Group (FRG)
- ANNX +4.6% (reports phase 2 clinical trial results demonstrating upstream classical complement inhibition associated with clinical benefit in Huntington's disease)
- NVAX +3.7% (FDA will hold meeting regarding NVAX COVID-19 vaccine for individuals 18 and older today at 8:30 ET)
- VERU +2.7% (Tang Capital discloses 5.2% stake; submits emergency use authorization application to U.S. FDA for Sabizabulin)
- FRG +2.7% (KSS Board of Directors enters into three-week exclusive negotiations with Franchise Group (FRG)
- DNA +1.4% (collaboration with Novo Nordisk (NVO) to create novel expression hosts for pharmaceutical products)
- RELY +1.1% (names new CFO)
- FSM +1.1% (drills 18.3 g/t gold over 11.9 meters at the Séguéla Project, Côte d'Ivoire)
- LSCC +1% (expands partnership with AMI)
- PTON +1% (CFO to step down; names new CFO)
Analyst comments:
- MRTX +4.5% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities)
- ARCH +2.5% (upgraded to Buy from Hold at Jefferies)
- NVO +2.1% (upgraded to Overweight from Neutral at JP Morgan)
- BTU +1.8% (upgraded to Buy from Hold at Jefferies)
- METC +1.5% (upgraded to Buy from Hold at Jefferies)
- RIO +1.4% (upgraded to Buy from Hold at Jefferies)
- ABC +0.9% (upgraded to Buy from Hold at Deutsche Bank)